Content Object
(
    [className] => Content
    [contentLinks] => Array
        (
        )

    [belongsTo] => 
    [contentIssue] => 
    [id] => 310458
    [pageNumber] => 
    [offset] => 
    [totalPages] => 
    [last_query] => 
    [last_sql] => 
    [show_errors] => 1
    [databaseServer] => Array
        (
            [key] => master
            [host] => 172.24.16.232
            [user] => rodpub_beta
            [pass] => MvQQzhse92k58yA
            [db] => rodpub_beta
        )

    [tableName] => contents
    [content_type_id] => 2487
    [resource_id] => 0
    [author_id] => 0
    [primary_issue_slug] => 
    [author_name] => {"name":"Mack Molding","title":""}
    [magazine_id] => 6
    [layout_id] => 0
    [primary_image] => 185360
    [primary_image_old] => 
    [slider_image_id] => 185360
    [banner_image] => 0
    [title] => Mack Rolling Out Tulip Manufacturing App Platform
    [short_title] => 
    [summary] => Tulip connects workers, machines, and IT systems to provide real-time insight into operations.
    [slug] => mack-rolling-out-tulip-manufacturing-app-platform
    [body] => Mack Molding has expanded its relationship with Tulip, the manufacturing app platform. Tulip's cloud-based platform augments the productivity of Mack's workforce with shop-floor apps, industrial IoT and real-time analytics.

"It is similar to a manufacturing execution system, only better," said headquarters plant manager Rich Hornby. "With big pictures, interactive elements and videos it is more efficient than paper-based work instructions when training new operators. Real-time data allows our team to rapidly recall information, ensuring we don't find out tomorrow there was a problem today. Tulip also provides us with a platform to easily share data with our customers as they are just a click away."

Mack has been testing Tulip at its headquarters for approximately one year, and will now begin rolling out the digital factory management software throughout the facility. The program allows Mack's manufacturing and quality engineers to build apps on their own, enabling better operator training and increased productivity through guided, interactive work instructions. In addition, the apps validate data on entry, record KPIs, cycle-time data, collect critical data for customer traceability and track gauges, calibrations and due dates, all in real-time.

"It is highly customizable," Hornby noted. "We like to say it is open to what your imagination can handle. Most importantly it puts the power of information, and the ability to act on it, into the hands of our front-line engineers, supervisors and operators. This gives them the ability to drive productivity and direct continuous improvement efforts."

"We're thrilled about this expansion with Mack," added Tulip's head of customer operations, Erik Mirandette. "We're excited to see how they continue innovating with manufacturing apps and leading the way in their space".

Tulip, a manufacturing app platform, is being used by manufacturers around the world to increase the productivity, quality and efficiency of their operations. Launched out of the Massachusetts Institute of Technology, the company is headquartered in Somerville, Mass., with offices in the United Kingdom and Germany. It has been recognized as a Gartner Cool Vendor, IDC Innovator, Frost and Sullivan Entrepreneurial Company of the year, an AWS Partner Network member and a World Economic Forum Technology Pioneer. Learn more at Tulip.co.

Mack Molding is a custom plastics molder and supplier of contract manufacturing services. Mack specializes in plastics design, prototyping, molding, sheet metal fabrication, full-service machining and medical device manufacturing. Founded in 1920, Mack is a privately owned business that operates 11 facilities throughout the world. The company is based in Arlington, Vt.  [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2019-03-21 09:27:00 [updated_at] => 2019-03-21 09:35:53 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["302199","310172","304290","301364","305414","299946","304245","301830","299788","302539","302284","308165","302816","309546"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 [contentType] => ContentType Object ( [className] => ContentType [content] => Array ( ) [taxonomy] => Array ( ) [listURL] => [logoUrl] => https: [id] => 2487 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => content_types [tag] => breaking_news [short_tag] => breaking_news [class_name] => [display_view] => [list_view] => [slug] => breaking-news [box_view] => [ignore_flag] => 0 [image_id] => 0 [layout_id] => 0 [formattedTag] => Breaking News ) [viewURL] => /contents/view_breaking-news/2019-03-21/mack-rolling-out-tulip-manufacturing-app-platform/ [relatedArticles] => Array ( [0] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 299788 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Marika Yang","title":"Carnegie Mellon University"} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 175883 [primary_image_old] => [slider_image_id] => 175883 [banner_image] => 0 [title] => AI System Finds Subtle Clues in Medical Images [short_title] => [summary] => [slug] => ai-system-finds-subtle-clues-in-medical-images [body] => Carnegie Mellon University alumna Shinjini Kundu is using artificial intelligence to interpret medical images in ways that humans cannot. Her program, 3D Transport-Based Morphometry, could significantly impact diagnoses and treatments for diseases.
 
“Some statistics say that up to 80 percent of all medical diagnoses are made or confirmed through imaging studies. As imaging machines have only gotten better, I wondered whether there could be subtle information important for disease recognition that was eluding human detection,” Kundu said. “I thought that if we could find hidden patterns, they may indicate emergence of disease in a way we hadn’t been thinking about. That was the motivation behind 3D TBM.”
 
Kundu, who earned her Ph.D. and M.D. degrees as part of the Medical Scientist Training Program (MSTP) at Carnegie Mellon (Biomedical Engineering) and the University of Pittsburgh, found that 3D TBM can find evidence of disease from medical images that humans can’t see, and that evidence can help predict diseases even before visible or physical symptoms develop. 
 
One of the diseases Kundu studied was osteoarthritis. Using 3D TBM, she was able to see very subtle changes in the medical images of knee cartilage of otherwise healthy people. These changes identified by 3D TBM could predict whether someone will develop osteoarthritis three years in the future with up to 86 percent accuracy.
 
Kundu’s 3D TBM program lives at the intersection of two of her interests, engineering and medicine, and aims to find the synergism between new innovative technologies and pushing the limits of medical diagnosis, detection, and treatment. When she initially designed the program as a Ph.D. candidate in biomedical engineering at Carnegie Mellon, Kundu said she had not originally planned to incorporate the artificial intelligence and machine learning component.
 
“I didn't necessarily think that I would be working on a machine learning project when I first started,” she said. “I just thought that this is a really cool idea, an important problem, and one that I could solve by applying the engineering skills that I'd learned. It was an opportunity to grow as an engineer and also solve an important problem in medical diagnosis. Now, having built this, I see that machine learning is a big component of it.”
 
When Kundu was deciding where she wanted to continue her education after graduating from Stanford, Carnegie Mellon’s College of Engineering for its front-of-the-line research and technology and interdisciplinary values.
 
“I wanted to be a part of the cutting-edge work going on at CMU,” she said. “There are so many interesting projects and ideas that there isn’t enough time in the world to take part in all of them. It’s a privilege. I had the opportunity to learn from so many bright people who are there. As I progress in my career, what I learned at CMU—how to think like an engineer and how to approach problems like an engineer—is going to stay with me.”
 
Earlier this year, Kundu was named one of the Massachusetts Institute of Technology Review’s 35 Innovators Under 35. Today, she works as a research scientist and holds a resident physician position at the University of Pittsburgh Medical Center, continuing to pursue both of her passions. She is working on further developing 3D TBM, studying different diseases and physical conditions with the program.
 
“Right now, I’m still working toward getting 3D TBM into the clinic, into the hands of doctors, and ultimately enabling better patient care,” she said. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-10-09 08:00:00 [updated_at] => 2018-10-08 14:43:26 [last_updated_author] => 199474 [uploaded_by] => 199474 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["288914","281126","279731","279340","291340","283845","282213","296193","296541","278240","278606","290009","283033","299799","292672","291350","278070","290597"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [1] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 299946 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Business Wire","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 176010 [primary_image_old] => [slider_image_id] => 176010 [banner_image] => 0 [title] => Zingbox Partners With the Medical Device Innovation, Safety and Security Consortium [short_title] => [summary] => Union will deliver key information to enable optimally configured and secured devices for patient safety and privacy. [slug] => zingbox-partners-with-the-medical-device-innovation-safety-and-security-consortium [body] => Zingbox, provider of the most widely deployed healthcare Internet of Things (IoT) analytics platform, has announced a strategic partnership with the non-profit Medical Device Innovation, Safety and Security Consortium (MDISS). Working together, the two organizations will advance best practices for the acquisition and sharing of cyber risk data for medical devices. The partnership will deliver in real time key information to enable optimally configured and secured devices for patient safety and privacy.
 
Zingbox will incorporate MDISS risk content, including Manufacturer Disclosure Statement for Medical Device Security (MDS2) information based on access control protocols developed by MDISS with input from leading manufacturers and health systems, into the Zingbox IoT Guardian solution.
 
The combination of Zingbox’s real-time analysis of medical device security, manufacturer device specifications, and standards-based risk assessment data will advance the overall security and safety of connected medical devices. In addition, integrating real-world device usage and behavior analytics will augment the existing MDISS cyber risk database with detailed inner workings of the device and network along with cybersecurity events.
 
Zingbox is the foundational member of the MDISS healthcare cyber safety and data services program, demonstrating its commitment to working closely across the medical device and care delivery ecosystem to tackle the industry’s cybersecurity challenges.
 
“Ultimately,” explained Xu Zou, CEO of Zingbox, “the MDISS and Zingbox partnership will provide comprehensive and actionable device context for healthcare providers, enabling them to better assess the threats and vulnerabilities of their connected medical devices while improving overall security for the medical device industry. We believe medical device security cannot be fully addressed by any single stakeholder but rather through collaboration and partnership across providers, device manufacturers, and technology vendors. This is why Zingbox has taken a position to be the first to partner with MDISS to marry the device-level cybersecurity vulnerabilities and specifications with real-time device risk and threat analytics for the betterment of the entire healthcare industry.”
 
The Zingbox-MDISS partnership will foster cross-industry collaboration through sharing of high-quality and timely cyber risk data to secure patients and communities. In addition, it will further extend the utility of the Zingbox solution to healthcare providers and device vendors to improve device security and ensure uninterrupted quality care.
 
“We are excited to partner with Zingbox, the first to market with a dedicated medical device cybersecurity solution. Our partnership will involve close collaboration with our community of practice to advance data and informatics best practices to support medical device network operations and cyber incident detection and response and deliver important insights to advance medical device innovation,” said Dr. Dale Nordenberg, MDISS executive director. “We share a sense of urgency to advance transparency of medical device cybersecurity specifications. Importantly, we are working with stakeholders to define and deliver the appropriate access controls for these data.”
 
Founded in 2010, MDISS is a 501(c)(3) non-profit public/private partnership dedicated to advancing patient safety and public health and the first to focus exclusively on medical device cybersecurity. MDISS develops and delivers practical technology, operations and policy solutions for member organizations, including hospitals, health delivery organizations, doctors, epidemiologists, clinical engineers, medical device manufacturers, academics, regulators, embedded security experts, and cybersecurity researchers.
 
Zingbox is the provider of the most widely deployed healthcare Internet of Things (IoT) analytics platform. Recently named a Cool Vendor in IoT Security by Gartner and recipient of the Stevie Award for Most Innovative Company, Zingbox helps hospitals realize the full potential of their IoT medical devices, delivering a new standard for uninterrupted quality care through device inventory, management, security, and optimization for the entire IoT environment. The company’s device-specific AI-powered machine learning platform uses the first real-time deep behavioral learning technology for connected medical devices.  [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-10-10 11:14:00 [updated_at] => 2018-10-10 11:22:41 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["279720","290022","289756","282689","289741","299795","279074","282671","282673","296459","264713","299451","298767","294222","288229","278237"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [2] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 301364 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Zingbox","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 177139 [primary_image_old] => [slider_image_id] => 177139 [banner_image] => 0 [title] => Zingbox Identifies New Trend in Cyber Attacks Targeting Connected Medical IoT Devices [short_title] => [summary] => Research shows hackers can 'trick' or induce medical devices into sharing detailed data about the device’s inner workings. [slug] => zingbox-identifies-new-trend-in-cyber-attacks-targeting-connected-medical-iot-devices [body] => Zingbox, provider of the most widely deployed healthcare Internet of Things (IoT) analytics platform, has announced new research demonstrating that hackers are leveraging error messages from connected medical devices—including radiology, X-ray and other imaging systems—to gain valuable insights. These insights are then used to refine the attacks, increasing the chance of a successful hack.
 
“Hackers are finding new and creative ways to target connected medical devices. We have to be in front of these trends and vulnerabilities before they can cause real harm,” said Xu Zou, Zingbox CEO and co-founder. “We make it our mission to assist and collaborate with device manufacturers to ensure the security and uninterrupted service of connected medical devices.”
 
Information gathering phase of a typical cyberattack is very time intensive phase where hackers learn as much as they can about the target network and devices. By simply monitoring the network traffic for common error messages, hackers can gain valuable insight into the inner workings of a device’s application; the type of web server, framework and versions used; the manufacturer that developed it; the database engine in the back end; the protocols used; and even the line of code that is causing the error. Hackers can also target specific devices to induce error messages. With this information, the information gathering phase is greatly shortened and they can quickly customize their attack to be tailored to the target device.
 
Zingbox’s research discovered that:

“Imagine how much more effective hackers can be if they find out that a device is running on IIS Web Server, using Oracle as backend and even gathering usernames,” said Daniel Regalado, principal security researcher at Zingbox and co-author of Gray Hat Hacking. “That will help them to focus their attack vectors towards the database where PHI data might be stored.”
 
The research also revealed that the healthcare industry has made great strides in collaborating across providers, vendors and manufacturers: there was rapid response and a willingness to generate patches for their medical devices from three out of seven manufacturers whose devices were included in the study. However, there is still work to be done to bring the urgency of these findings as well as increased collaboration between security vendors and device manufacturers.
 
Zingbox is the provider of the most widely deployed healthcare Internet of Things (IoT) analytics platform. Recently named a Cool Vendor in IoT Security by Gartner and recipient of the Stevie Award for Most Innovative Company, Zingbox helps hospitals realize the full potential of their IoT medical devices, delivering a new standard for uninterrupted quality care through device inventory, management, security, and optimization for the entire IoT environment. The company’s device-specific AI-powered machine learning platform uses the first real-time deep behavioral learning technology for connected medical devices. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-10-31 08:57:00 [updated_at] => 2018-10-31 09:03:01 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["299946","279720","298473","290454","280159","296459","285042","297561","292027","289758","282689","294261","289761","291498","294052","289785","288343"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [3] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 301830 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Business Wire","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 177556 [primary_image_old] => [slider_image_id] => 177556 [banner_image] => 0 [title] => LuxCath Appoints Chief Technology Officer [short_title] => [summary] => Company also adds two medtech veterans to its Board of Directors. [slug] => luxcath-appoints-chief-technology-officer [body] => LuxCath LLC, a medical device company developing a cardiac catheter ablation technology, has appointed Terry Ransbury as chief technology officer. Ransbury is a seasoned industry veteran who brings over 30 years of experience in research and development, specializing in electrophysiology and cardiac rhythm management. He will spearhead the development and commercialization of LuxCath’s proprietary OmniView light-guided catheter ablation system, the only technology to see into tissue during cardiac ablation for assessing catheter-tissue contact and lesion progression in real-time. The OmniView technology provides electrophysiologists with a simple, definitive endpoint for lesion quality, thus increasing the potential for complete and more rapid, effective cardiac ablation.
 
“We are thrilled to have someone of Terry’s caliber lead our development efforts and help us fully realize the potential of our breakthrough light-guided ablation technology,” said Omar Amirana, M.D., CEO of LuxCath. “Terry’s extensive experience in research and development, as well as long-standing relationships with leading electrophysiologists, will be important as we focus on our immediate goal of bringing our technology to market.”
 
“I believe LuxCath has the transformative science and encouraging data to revolutionize the treatment of cardiac arrhythmias,” said Ransbury. “I have worked with this technology since its inception and am confident of its potential to improve patient outcomes, reduce procedure times and costly repeat ablations. The electrophysiology market stands to significantly benefit from this remarkable breakthrough and I am thrilled to join LuxCath as its first full-time employee.”
 
Ransbury has participated in over 600 human cardiac ablation procedures around the world and is EP-lab certified. He has several years of industry experience, having previously served at startups, such as Ventritex (now part of St. Jude Medical/Abbott) and Biosense (now part of Johnson & Johnson). He has a bachelor’s degree in electrical engineering and biomedical engineering from Duke University and is listed as the inventor on over 40 U.S. patents and patent applications. Most recently, Ransbury served as co-founder and president at Nocturnal Product Development, a medical device development firm, where he was responsible for new business development, system architecture design, and project management. Nocturnal Product Development has served as LuxCath’s product development partner since inception and has been instrumental in developing the company’s core technology to date.
 
“Although we are sad to see Terry leave Nocturnal, I am extremely proud of the progress we have made with LuxCath and welcome the prospect of continuing our partnership and seeing through the development of this hugely innovative technology,” said K.C. Armstrong, co-founder and newly appointed president at Nocturnal Product Development.
 
Separately, LuxCath has appointed to its board Rick Randall and John Fletcher. The appointments are effective immediately and increases the size of LuxCath’s board to five members.
 
“Rick and John are two highly regarded industry veterans and their appointments to our board of directors reflects the disruptive potential we believe our technology offers electrophysiologists,” said Amirana. “Rick and John will both be instrumental in providing valuable insights regarding our operations, strategy, and corporate governance. We are delighted to welcome them both and look forward to leveraging their knowledge as we move towards a CE Mark and EU commercialization.”
 
Randall has over 40 years of experience in the medical device industry and has held various leadership and board positions. Most recently, Randall served as CEO of OMNIlife Science Inc., the first company to commercialize robotic-assisted total knee replacement in the United States. Before OMNI, he served as CEO of Innovasive Devices Inc., acquired by Johnson & Johnson in 2000, and Target Therapeutics Inc., acquired by Boston Scientific Corp. in 1997. In addition, Randall currently serves as a board advisor at RadiaDyne LLC and director at Fortus Medical Inc. Randall has previously served on the boards of several medical device companies, including Endocardial Solutions Inc. and Conceptus Inc.
 
Fletcher serves as the CEO and managing director of Fletcher Spaght Inc., which he founded in 1983. He is a founding partner and managing director at Fletcher Spaght Ventures LP. Prior to launching Fletcher Spaght Inc., he served as a senior manager at The Boston Consulting Group, managing client relationships in healthcare and high technology companies. Fletcher has extensive work experience in strategic planning, especially in the area of market analysis for technology-based businesses. He served as board chairman of The Spectranetics Corporation from December 2010 until its acquisition by Philips in August 2017. For his work at Spectranetics, he was named Director of the Year by the National Association of Corporate Directors. He currently serves on the boards of Axcelis Technologies Inc., MRI Interventions Inc., and Metabolon. He is also on the Boards of Advisors of the Whitehead Institute at the Massachusetts Institute of Technology, the Thayer School of Engineering at Dartmouth College, and the School of Government and Business at The George Washington University. Fletcher previously served on the boards of NMT Medical, Marina Biotech Inc., AutoImmune, and Cayenne Software Inc. Fletcher was a captain and fighter pilot in the U.S. Air Force.
 
LuxCath is a medical technology company founded to address persistent unmet needs in the catheter ablation treatment of cardiac arrhythmias. The company has developed technology that uses fluorescence and optics to directly view lesions during cardiac ablation procedures. Its flagship product, the OmniView light-guided ablation catheter, allows electrophysiologists for the first time to see and assess catheter-tissue contact quality, tissue composition and lesion quality in real time during the procedure, increasing the potential for complete and effective cardiac ablation.
 
Nocturnal Product Development LLC is a medical device development firm located near Research Triangle Park, Durham, N.C. The company specializes in multi-disciplinary technology product development with expertise in: electrical design, mechanical design, embedded software, optics, IOT, wireless, cloud-based applications, project management, and clinical & regulatory strategy.
 
Allied Minds is an innovative U.S. science and technology development and commercialization company based in Boston, Mass. Operating since 2006, Allied Minds forms, funds, manages and builds products and businesses based on technologies developed at U.S. universities and federal research institutions. Allied Minds serves as a diversified holding company that supports its businesses and product development with capital, central management and shared services. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-11-07 09:07:00 [updated_at] => 2018-11-07 09:20:59 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["288355","284243","283843","283027","281424","289758","283532","283232","299472","282690","288233","281107","297162","284769","288054","301358","283580","296393","296990","284028"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [4] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 302199 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Mack Molding","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 177889 [primary_image_old] => [slider_image_id] => 177889 [banner_image] => 0 [title] => Mack Molding Promotes Business Development Director to Top Sales Role [short_title] => [summary] => Company combines northern and southern divisions' business development teams. [slug] => mack-molding-promotes-business-development-director-to-top-sales-role [body] => Mack Molding, a custom plastics molder and supplier of contract manufacturing services, is uniting the business development teams of its northern and southern divisions under the leadership of Jonathan Whitney, the company's director of business development. Within this role, Whitney joins Mack's senior staff, reporting directly to President Jeff Somple with dotted-line responsibility to Mack South President Bryan Campbell.

"Jon is a seasoned member of the Mack family and an accomplished engineer," Somple said. "During his tenure with us he has consistently shown a keen ability to target new markets, driving sales growth and increased diversity in our customer base. Unifying our sales teams under Jon not only reflects his contributions to the organization, it allows us to bring increased focus and strategic execution to the prospecting and onboarding of new customers."

Whitney, who has served as the director of business development for the company's Northern Division since 2016, first joined Mack in 2013 as a business development manager for New England. An expert in contract manufacturing, plastics and medical devices, he previously was a senior project manager for the design, development and commercialization of cardiovascular devices at Abiomed. He gained other engineering experience at Olympus, Alkermes and Raytheon, where he earned a green belt six-sigma certification. Whitney has an M.B.A. from Babson College in Wellesley, Mass.; a masters degree in engineering management from Tufts University in Boston; and a bachelors in plastics engineering from UMass Lowell.

Mack Molding is a custom plastics molder and supplier of contract manufacturing services. Mack specializes in plastics design, prototyping, molding, sheet metal fabrication, full-service machining and medical device manufacturing. Founded in 1920, Mack is a privately owned business that operates 11 facilities throughout the world. Don Kendall is CEO and chairman. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-11-13 02:34:00 [updated_at] => 2018-11-13 02:47:50 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["283359","299793","299872","300573","299654","282554","289756","289787","290022","299086","283374"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) ) [relatedContent] => Array ( [0] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 299788 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Marika Yang","title":"Carnegie Mellon University"} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 175883 [primary_image_old] => [slider_image_id] => 175883 [banner_image] => 0 [title] => AI System Finds Subtle Clues in Medical Images [short_title] => [summary] => [slug] => ai-system-finds-subtle-clues-in-medical-images [body] => Carnegie Mellon University alumna Shinjini Kundu is using artificial intelligence to interpret medical images in ways that humans cannot. Her program, 3D Transport-Based Morphometry, could significantly impact diagnoses and treatments for diseases.
 
“Some statistics say that up to 80 percent of all medical diagnoses are made or confirmed through imaging studies. As imaging machines have only gotten better, I wondered whether there could be subtle information important for disease recognition that was eluding human detection,” Kundu said. “I thought that if we could find hidden patterns, they may indicate emergence of disease in a way we hadn’t been thinking about. That was the motivation behind 3D TBM.”
 
Kundu, who earned her Ph.D. and M.D. degrees as part of the Medical Scientist Training Program (MSTP) at Carnegie Mellon (Biomedical Engineering) and the University of Pittsburgh, found that 3D TBM can find evidence of disease from medical images that humans can’t see, and that evidence can help predict diseases even before visible or physical symptoms develop. 
 
One of the diseases Kundu studied was osteoarthritis. Using 3D TBM, she was able to see very subtle changes in the medical images of knee cartilage of otherwise healthy people. These changes identified by 3D TBM could predict whether someone will develop osteoarthritis three years in the future with up to 86 percent accuracy.
 
Kundu’s 3D TBM program lives at the intersection of two of her interests, engineering and medicine, and aims to find the synergism between new innovative technologies and pushing the limits of medical diagnosis, detection, and treatment. When she initially designed the program as a Ph.D. candidate in biomedical engineering at Carnegie Mellon, Kundu said she had not originally planned to incorporate the artificial intelligence and machine learning component.
 
“I didn't necessarily think that I would be working on a machine learning project when I first started,” she said. “I just thought that this is a really cool idea, an important problem, and one that I could solve by applying the engineering skills that I'd learned. It was an opportunity to grow as an engineer and also solve an important problem in medical diagnosis. Now, having built this, I see that machine learning is a big component of it.”
 
When Kundu was deciding where she wanted to continue her education after graduating from Stanford, Carnegie Mellon’s College of Engineering for its front-of-the-line research and technology and interdisciplinary values.
 
“I wanted to be a part of the cutting-edge work going on at CMU,” she said. “There are so many interesting projects and ideas that there isn’t enough time in the world to take part in all of them. It’s a privilege. I had the opportunity to learn from so many bright people who are there. As I progress in my career, what I learned at CMU—how to think like an engineer and how to approach problems like an engineer—is going to stay with me.”
 
Earlier this year, Kundu was named one of the Massachusetts Institute of Technology Review’s 35 Innovators Under 35. Today, she works as a research scientist and holds a resident physician position at the University of Pittsburgh Medical Center, continuing to pursue both of her passions. She is working on further developing 3D TBM, studying different diseases and physical conditions with the program.
 
“Right now, I’m still working toward getting 3D TBM into the clinic, into the hands of doctors, and ultimately enabling better patient care,” she said. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-10-09 08:00:00 [updated_at] => 2018-10-08 14:43:26 [last_updated_author] => 199474 [uploaded_by] => 199474 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["288914","281126","279731","279340","291340","283845","282213","296193","296541","278240","278606","290009","283033","299799","292672","291350","278070","290597"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [1] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 299946 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Business Wire","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 176010 [primary_image_old] => [slider_image_id] => 176010 [banner_image] => 0 [title] => Zingbox Partners With the Medical Device Innovation, Safety and Security Consortium [short_title] => [summary] => Union will deliver key information to enable optimally configured and secured devices for patient safety and privacy. [slug] => zingbox-partners-with-the-medical-device-innovation-safety-and-security-consortium [body] => Zingbox, provider of the most widely deployed healthcare Internet of Things (IoT) analytics platform, has announced a strategic partnership with the non-profit Medical Device Innovation, Safety and Security Consortium (MDISS). Working together, the two organizations will advance best practices for the acquisition and sharing of cyber risk data for medical devices. The partnership will deliver in real time key information to enable optimally configured and secured devices for patient safety and privacy.
 
Zingbox will incorporate MDISS risk content, including Manufacturer Disclosure Statement for Medical Device Security (MDS2) information based on access control protocols developed by MDISS with input from leading manufacturers and health systems, into the Zingbox IoT Guardian solution.
 
The combination of Zingbox’s real-time analysis of medical device security, manufacturer device specifications, and standards-based risk assessment data will advance the overall security and safety of connected medical devices. In addition, integrating real-world device usage and behavior analytics will augment the existing MDISS cyber risk database with detailed inner workings of the device and network along with cybersecurity events.
 
Zingbox is the foundational member of the MDISS healthcare cyber safety and data services program, demonstrating its commitment to working closely across the medical device and care delivery ecosystem to tackle the industry’s cybersecurity challenges.
 
“Ultimately,” explained Xu Zou, CEO of Zingbox, “the MDISS and Zingbox partnership will provide comprehensive and actionable device context for healthcare providers, enabling them to better assess the threats and vulnerabilities of their connected medical devices while improving overall security for the medical device industry. We believe medical device security cannot be fully addressed by any single stakeholder but rather through collaboration and partnership across providers, device manufacturers, and technology vendors. This is why Zingbox has taken a position to be the first to partner with MDISS to marry the device-level cybersecurity vulnerabilities and specifications with real-time device risk and threat analytics for the betterment of the entire healthcare industry.”
 
The Zingbox-MDISS partnership will foster cross-industry collaboration through sharing of high-quality and timely cyber risk data to secure patients and communities. In addition, it will further extend the utility of the Zingbox solution to healthcare providers and device vendors to improve device security and ensure uninterrupted quality care.
 
“We are excited to partner with Zingbox, the first to market with a dedicated medical device cybersecurity solution. Our partnership will involve close collaboration with our community of practice to advance data and informatics best practices to support medical device network operations and cyber incident detection and response and deliver important insights to advance medical device innovation,” said Dr. Dale Nordenberg, MDISS executive director. “We share a sense of urgency to advance transparency of medical device cybersecurity specifications. Importantly, we are working with stakeholders to define and deliver the appropriate access controls for these data.”
 
Founded in 2010, MDISS is a 501(c)(3) non-profit public/private partnership dedicated to advancing patient safety and public health and the first to focus exclusively on medical device cybersecurity. MDISS develops and delivers practical technology, operations and policy solutions for member organizations, including hospitals, health delivery organizations, doctors, epidemiologists, clinical engineers, medical device manufacturers, academics, regulators, embedded security experts, and cybersecurity researchers.
 
Zingbox is the provider of the most widely deployed healthcare Internet of Things (IoT) analytics platform. Recently named a Cool Vendor in IoT Security by Gartner and recipient of the Stevie Award for Most Innovative Company, Zingbox helps hospitals realize the full potential of their IoT medical devices, delivering a new standard for uninterrupted quality care through device inventory, management, security, and optimization for the entire IoT environment. The company’s device-specific AI-powered machine learning platform uses the first real-time deep behavioral learning technology for connected medical devices.  [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-10-10 11:14:00 [updated_at] => 2018-10-10 11:22:41 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["279720","290022","289756","282689","289741","299795","279074","282671","282673","296459","264713","299451","298767","294222","288229","278237"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [2] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 301364 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Zingbox","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 177139 [primary_image_old] => [slider_image_id] => 177139 [banner_image] => 0 [title] => Zingbox Identifies New Trend in Cyber Attacks Targeting Connected Medical IoT Devices [short_title] => [summary] => Research shows hackers can 'trick' or induce medical devices into sharing detailed data about the device’s inner workings. [slug] => zingbox-identifies-new-trend-in-cyber-attacks-targeting-connected-medical-iot-devices [body] => Zingbox, provider of the most widely deployed healthcare Internet of Things (IoT) analytics platform, has announced new research demonstrating that hackers are leveraging error messages from connected medical devices—including radiology, X-ray and other imaging systems—to gain valuable insights. These insights are then used to refine the attacks, increasing the chance of a successful hack.
 
“Hackers are finding new and creative ways to target connected medical devices. We have to be in front of these trends and vulnerabilities before they can cause real harm,” said Xu Zou, Zingbox CEO and co-founder. “We make it our mission to assist and collaborate with device manufacturers to ensure the security and uninterrupted service of connected medical devices.”
 
Information gathering phase of a typical cyberattack is very time intensive phase where hackers learn as much as they can about the target network and devices. By simply monitoring the network traffic for common error messages, hackers can gain valuable insight into the inner workings of a device’s application; the type of web server, framework and versions used; the manufacturer that developed it; the database engine in the back end; the protocols used; and even the line of code that is causing the error. Hackers can also target specific devices to induce error messages. With this information, the information gathering phase is greatly shortened and they can quickly customize their attack to be tailored to the target device.
 
Zingbox’s research discovered that:

“Imagine how much more effective hackers can be if they find out that a device is running on IIS Web Server, using Oracle as backend and even gathering usernames,” said Daniel Regalado, principal security researcher at Zingbox and co-author of Gray Hat Hacking. “That will help them to focus their attack vectors towards the database where PHI data might be stored.”
 
The research also revealed that the healthcare industry has made great strides in collaborating across providers, vendors and manufacturers: there was rapid response and a willingness to generate patches for their medical devices from three out of seven manufacturers whose devices were included in the study. However, there is still work to be done to bring the urgency of these findings as well as increased collaboration between security vendors and device manufacturers.
 
Zingbox is the provider of the most widely deployed healthcare Internet of Things (IoT) analytics platform. Recently named a Cool Vendor in IoT Security by Gartner and recipient of the Stevie Award for Most Innovative Company, Zingbox helps hospitals realize the full potential of their IoT medical devices, delivering a new standard for uninterrupted quality care through device inventory, management, security, and optimization for the entire IoT environment. The company’s device-specific AI-powered machine learning platform uses the first real-time deep behavioral learning technology for connected medical devices. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-10-31 08:57:00 [updated_at] => 2018-10-31 09:03:01 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["299946","279720","298473","290454","280159","296459","285042","297561","292027","289758","282689","294261","289761","291498","294052","289785","288343"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [3] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 301830 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Business Wire","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 177556 [primary_image_old] => [slider_image_id] => 177556 [banner_image] => 0 [title] => LuxCath Appoints Chief Technology Officer [short_title] => [summary] => Company also adds two medtech veterans to its Board of Directors. [slug] => luxcath-appoints-chief-technology-officer [body] => LuxCath LLC, a medical device company developing a cardiac catheter ablation technology, has appointed Terry Ransbury as chief technology officer. Ransbury is a seasoned industry veteran who brings over 30 years of experience in research and development, specializing in electrophysiology and cardiac rhythm management. He will spearhead the development and commercialization of LuxCath’s proprietary OmniView light-guided catheter ablation system, the only technology to see into tissue during cardiac ablation for assessing catheter-tissue contact and lesion progression in real-time. The OmniView technology provides electrophysiologists with a simple, definitive endpoint for lesion quality, thus increasing the potential for complete and more rapid, effective cardiac ablation.
 
“We are thrilled to have someone of Terry’s caliber lead our development efforts and help us fully realize the potential of our breakthrough light-guided ablation technology,” said Omar Amirana, M.D., CEO of LuxCath. “Terry’s extensive experience in research and development, as well as long-standing relationships with leading electrophysiologists, will be important as we focus on our immediate goal of bringing our technology to market.”
 
“I believe LuxCath has the transformative science and encouraging data to revolutionize the treatment of cardiac arrhythmias,” said Ransbury. “I have worked with this technology since its inception and am confident of its potential to improve patient outcomes, reduce procedure times and costly repeat ablations. The electrophysiology market stands to significantly benefit from this remarkable breakthrough and I am thrilled to join LuxCath as its first full-time employee.”
 
Ransbury has participated in over 600 human cardiac ablation procedures around the world and is EP-lab certified. He has several years of industry experience, having previously served at startups, such as Ventritex (now part of St. Jude Medical/Abbott) and Biosense (now part of Johnson & Johnson). He has a bachelor’s degree in electrical engineering and biomedical engineering from Duke University and is listed as the inventor on over 40 U.S. patents and patent applications. Most recently, Ransbury served as co-founder and president at Nocturnal Product Development, a medical device development firm, where he was responsible for new business development, system architecture design, and project management. Nocturnal Product Development has served as LuxCath’s product development partner since inception and has been instrumental in developing the company’s core technology to date.
 
“Although we are sad to see Terry leave Nocturnal, I am extremely proud of the progress we have made with LuxCath and welcome the prospect of continuing our partnership and seeing through the development of this hugely innovative technology,” said K.C. Armstrong, co-founder and newly appointed president at Nocturnal Product Development.
 
Separately, LuxCath has appointed to its board Rick Randall and John Fletcher. The appointments are effective immediately and increases the size of LuxCath’s board to five members.
 
“Rick and John are two highly regarded industry veterans and their appointments to our board of directors reflects the disruptive potential we believe our technology offers electrophysiologists,” said Amirana. “Rick and John will both be instrumental in providing valuable insights regarding our operations, strategy, and corporate governance. We are delighted to welcome them both and look forward to leveraging their knowledge as we move towards a CE Mark and EU commercialization.”
 
Randall has over 40 years of experience in the medical device industry and has held various leadership and board positions. Most recently, Randall served as CEO of OMNIlife Science Inc., the first company to commercialize robotic-assisted total knee replacement in the United States. Before OMNI, he served as CEO of Innovasive Devices Inc., acquired by Johnson & Johnson in 2000, and Target Therapeutics Inc., acquired by Boston Scientific Corp. in 1997. In addition, Randall currently serves as a board advisor at RadiaDyne LLC and director at Fortus Medical Inc. Randall has previously served on the boards of several medical device companies, including Endocardial Solutions Inc. and Conceptus Inc.
 
Fletcher serves as the CEO and managing director of Fletcher Spaght Inc., which he founded in 1983. He is a founding partner and managing director at Fletcher Spaght Ventures LP. Prior to launching Fletcher Spaght Inc., he served as a senior manager at The Boston Consulting Group, managing client relationships in healthcare and high technology companies. Fletcher has extensive work experience in strategic planning, especially in the area of market analysis for technology-based businesses. He served as board chairman of The Spectranetics Corporation from December 2010 until its acquisition by Philips in August 2017. For his work at Spectranetics, he was named Director of the Year by the National Association of Corporate Directors. He currently serves on the boards of Axcelis Technologies Inc., MRI Interventions Inc., and Metabolon. He is also on the Boards of Advisors of the Whitehead Institute at the Massachusetts Institute of Technology, the Thayer School of Engineering at Dartmouth College, and the School of Government and Business at The George Washington University. Fletcher previously served on the boards of NMT Medical, Marina Biotech Inc., AutoImmune, and Cayenne Software Inc. Fletcher was a captain and fighter pilot in the U.S. Air Force.
 
LuxCath is a medical technology company founded to address persistent unmet needs in the catheter ablation treatment of cardiac arrhythmias. The company has developed technology that uses fluorescence and optics to directly view lesions during cardiac ablation procedures. Its flagship product, the OmniView light-guided ablation catheter, allows electrophysiologists for the first time to see and assess catheter-tissue contact quality, tissue composition and lesion quality in real time during the procedure, increasing the potential for complete and effective cardiac ablation.
 
Nocturnal Product Development LLC is a medical device development firm located near Research Triangle Park, Durham, N.C. The company specializes in multi-disciplinary technology product development with expertise in: electrical design, mechanical design, embedded software, optics, IOT, wireless, cloud-based applications, project management, and clinical & regulatory strategy.
 
Allied Minds is an innovative U.S. science and technology development and commercialization company based in Boston, Mass. Operating since 2006, Allied Minds forms, funds, manages and builds products and businesses based on technologies developed at U.S. universities and federal research institutions. Allied Minds serves as a diversified holding company that supports its businesses and product development with capital, central management and shared services. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-11-07 09:07:00 [updated_at] => 2018-11-07 09:20:59 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["288355","284243","283843","283027","281424","289758","283532","283232","299472","282690","288233","281107","297162","284769","288054","301358","283580","296393","296990","284028"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [4] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 302199 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Mack Molding","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 177889 [primary_image_old] => [slider_image_id] => 177889 [banner_image] => 0 [title] => Mack Molding Promotes Business Development Director to Top Sales Role [short_title] => [summary] => Company combines northern and southern divisions' business development teams. [slug] => mack-molding-promotes-business-development-director-to-top-sales-role [body] => Mack Molding, a custom plastics molder and supplier of contract manufacturing services, is uniting the business development teams of its northern and southern divisions under the leadership of Jonathan Whitney, the company's director of business development. Within this role, Whitney joins Mack's senior staff, reporting directly to President Jeff Somple with dotted-line responsibility to Mack South President Bryan Campbell.

"Jon is a seasoned member of the Mack family and an accomplished engineer," Somple said. "During his tenure with us he has consistently shown a keen ability to target new markets, driving sales growth and increased diversity in our customer base. Unifying our sales teams under Jon not only reflects his contributions to the organization, it allows us to bring increased focus and strategic execution to the prospecting and onboarding of new customers."

Whitney, who has served as the director of business development for the company's Northern Division since 2016, first joined Mack in 2013 as a business development manager for New England. An expert in contract manufacturing, plastics and medical devices, he previously was a senior project manager for the design, development and commercialization of cardiovascular devices at Abiomed. He gained other engineering experience at Olympus, Alkermes and Raytheon, where he earned a green belt six-sigma certification. Whitney has an M.B.A. from Babson College in Wellesley, Mass.; a masters degree in engineering management from Tufts University in Boston; and a bachelors in plastics engineering from UMass Lowell.

Mack Molding is a custom plastics molder and supplier of contract manufacturing services. Mack specializes in plastics design, prototyping, molding, sheet metal fabrication, full-service machining and medical device manufacturing. Founded in 1920, Mack is a privately owned business that operates 11 facilities throughout the world. Don Kendall is CEO and chairman. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-11-13 02:34:00 [updated_at] => 2018-11-13 02:47:50 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["283359","299793","299872","300573","299654","282554","289756","289787","290022","299086","283374"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) ) [relatedSearches] => Array ( [0] => Taxonomy Object ( [className] => Taxonomy [id] => 58003 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [taxonomy_tag] => app ) [1] => Taxonomy Object ( [className] => Taxonomy [id] => 65562 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [taxonomy_tag] => plastics ) [2] => Taxonomy Object ( [className] => Taxonomy [id] => 59046 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [taxonomy_tag] => testing ) [3] => Taxonomy Object ( [className] => Taxonomy [id] => 24577 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [taxonomy_tag] => Molding ) ) [contentTaxonomy_knowledge-center] => Array ( [0] => Taxonomy Object ( [className] => Taxonomy [id] => 8010 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [content_taxonomy_id] => 6489906 [slug] => molding [child_of] => 8021 [ignore_flag] => 0 [up3_tag] => [up2_tag] => Knowledge Center [up1_tag] => Supply Chain [taxonomy_tag] => Molding [up3_id] => [up2_id] => 7963 [up1_id] => 8021 [taxonomy_id] => 8010 [depth] => 2 ) ) [formattedTitle] => Mack Rolling Out Tulip Manufacturing App Platform [taxonomy_keywords] => Array ( [0] => Taxonomy Object ( [className] => Taxonomy [id] => 24551 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => Manufacturing [slug] => manufacturing [child_of] => 24495 ) [1] => Taxonomy Object ( [className] => Taxonomy [id] => 24577 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => Molding [slug] => molding [child_of] => 24495 ) [2] => Taxonomy Object ( [className] => Taxonomy [id] => 24602 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => Software [slug] => software [child_of] => 24495 ) [3] => Taxonomy Object ( [className] => Taxonomy [id] => 50352 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => medical device [slug] => medical-device [child_of] => 24495 ) [4] => Taxonomy Object ( [className] => Taxonomy [id] => 56425 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => germany [slug] => germany [child_of] => 24495 ) [5] => Taxonomy Object ( [className] => Taxonomy [id] => 56741 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => recall [slug] => recall [child_of] => 24495 ) [6] => Taxonomy Object ( [className] => Taxonomy [id] => 57471 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => apps [slug] => apps [child_of] => 24495 ) [7] => Taxonomy Object ( [className] => Taxonomy [id] => 57657 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => data [slug] => data [child_of] => 24495 ) [8] => Taxonomy Object ( [className] => Taxonomy [id] => 57660 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => cloud [slug] => cloud [child_of] => 24495 ) [9] => Taxonomy Object ( [className] => Taxonomy [id] => 57965 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => power [slug] => power [child_of] => 24495 ) [10] => Taxonomy Object ( [className] => Taxonomy [id] => 57973 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => machining [slug] => machining [child_of] => 24495 ) [11] => Taxonomy Object ( [className] => Taxonomy [id] => 57994 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => contract manufacturing [slug] => contract-manufacturing [child_of] => 24495 ) [12] => Taxonomy Object ( [className] => Taxonomy [id] => 57998 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => quality [slug] => quality [child_of] => 24495 ) [13] => Taxonomy Object ( [className] => Taxonomy [id] => 58003 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => app [slug] => app [child_of] => 24495 ) [14] => Taxonomy Object ( [className] => Taxonomy [id] => 58467 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => analytics [slug] => analytics [child_of] => 24495 ) [15] => Taxonomy Object ( [className] => Taxonomy [id] => 58573 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => metal [slug] => metal [child_of] => 24495 ) [16] => Taxonomy Object ( [className] => Taxonomy [id] => 58605 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => paper [slug] => paper [child_of] => 24495 ) [17] => Taxonomy Object ( [className] => Taxonomy [id] => 58829 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => design [slug] => design [child_of] => 24495 ) [18] => Taxonomy Object ( [className] => Taxonomy [id] => 59046 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => testing [slug] => testing [child_of] => 24495 ) [19] => Taxonomy Object ( [className] => Taxonomy [id] => 59514 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => iot [slug] => iot [child_of] => 24495 ) [20] => Taxonomy Object ( [className] => Taxonomy [id] => 61844 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => it [slug] => it [child_of] => 24495 ) [21] => Taxonomy Object ( [className] => Taxonomy [id] => 63660 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => medical [slug] => medical [child_of] => 24495 ) [22] => Taxonomy Object ( [className] => Taxonomy [id] => 63678 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => medical device manufacturing [slug] => medical-device-manufacturing [child_of] => 24495 ) [23] => Taxonomy Object ( [className] => Taxonomy [id] => 63698 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => track [slug] => track [child_of] => 24495 ) [24] => Taxonomy Object ( [className] => Taxonomy [id] => 63734 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => supplier [slug] => supplier [child_of] => 24495 ) [25] => Taxonomy Object ( [className] => Taxonomy [id] => 64227 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => company [slug] => company [child_of] => 24495 ) [26] => Taxonomy Object ( [className] => Taxonomy [id] => 64718 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => technology [slug] => technology [child_of] => 24495 ) [27] => Taxonomy Object ( [className] => Taxonomy [id] => 64954 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => institute [slug] => institute [child_of] => 24495 ) [28] => Taxonomy Object ( [className] => Taxonomy [id] => 65562 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => plastics [slug] => plastics [child_of] => 24495 ) [29] => Taxonomy Object ( [className] => Taxonomy [id] => 65642 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => mack molding [slug] => mack-molding [child_of] => 24495 ) [30] => Taxonomy Object ( [className] => Taxonomy [id] => 69780 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => system [slug] => system [child_of] => 24495 ) ) )